A fusion protein has been expressed from the relevant genes in mammalian cells consisting of the photoprotein aequorin and an anti-4-hydroxy-3-nitrophenacetyl antibody gene. This chimeric antibody has allowed the development of a sensitive luminescent immunoassay. Initially the cDNA of the photoprotein aequorin from Aequorea victoria was cloned and expressed in Escherichia coli. The gene was expressed as apoaequorin and, by using luciferin isolated from RenilUa reniformnis, its activity was found essentially identical to native aequorin. The aequorin gene was subcloned into a mammalian expression vector to produce a fusion protein directing secretion ofapoaequorin; the aequorin gene was fused to the 3' terminus of an immunoglobulin heavy-chain gene that directed expression of an anti-4-hydroxy-3-nitrophenacetyl antibody. The gene fusion contained the variable region, the constant region domain 1, and part of domain 2 for the IgG2b mouse immunoglobulin, followed by the aequorin gene. Transfection of the chimeric gene into a cell line expressing the complementary Al light chain, J558L, allowed recovery of a chimeric antibody with binding specificity for the 4-hydroxy-3-nitrophenacetyl group and the related 4-hydroxy-3-iodo-5-nitrophenacetyl hapten. The Ca2+-dependent bioluminescent activity of aequorin was also recovered.
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A variety of reporter molecules, such as radioisotopes, fluorescent and chemiluminescent molecules, and enzymes chemically linked to antibodies, have been used to quantify antigen-antibody interactions (1) . However, these chemical modifications can often lead to batch-to-batch variation, loss of binding activity, and, for the commonly used radioisotopes, short shelf lives. Genetically engineered chimeric antibodies in which all or part of the antibody constant region is replaced by an enzyme (2) or other protein capable of generating an appropriately amplified signal offer an alternative to chemical modification that eliminates the above disadvantages without incurring any loss of sensitivity. In yet another variation single-chain antibodies have been produced by two research groups in which the light-chain and heavychain variable regions are linked via a short hydrophilic polypeptide and subsequently expressed in both Escherichia coli (3) and Bacillus subtilis (4) systems. Secretion of functional antibodies either as intact antibody or fragments (Fab' or Fv) has also been achieved in E. coli (5, 6) and yeast (7) expression systems. The cloning and expression in E. coli of a single-chain antibody fused to a protein toxin molecule protein has also been reported (8) .
Enzyme-generated luminescence, as exemplified by the ATP-dependent firefly luciferase system (9) , is a particularly attractive system for application in immunodiagnostics due to its ease of detection and high sensitivity (10) . However, this system would be greatly improved if the binding protein (the antibody) and the enzyme were part of the same molecule. In this case, purification of the enzyme-antibody conjugate to homogeneity could be greatly facilitated by using immunoaffinity chromatography.
We selected the well-characterized luminescent protein aequorin from the circumoral ring of the hydromedusa Aequorea victoria. Aequorin emits light (Ama,, = 470 nm) on oxidation of bound luciferin, an imidazopyrazine (10) , in the presence of Ca2". This oxidation and the resulting photon flux is generated rapidly enough to discriminate 10-18 mol of photoprotein over background (10) . Because the luminescent reaction is Ca2' dependent and can be detected with high sensitivity, aequorin has been used as a biological Ca2+ indicator (11) . This generation of measurable luminescence at very low aequorin concentrations indicates that aequorin may be of value in immunoassay systems, provided a reliable and homogeneous source of the protein can be obtained and connected with an appropriate antigen-binding protein.
The recent cloning and sequencing of aequorin cDNAs has revealed that aequorin is composed of 1% amino acids and contains three EF-hand structures characteristic of Ca2+-binding domains. The amino acid sequences of the Ca2+-binding sites of bovine calmodulin, parvalbumin, and troponin C show strong sequence similarity to the proposed sites in aequorin (12) .
Recent techniques in the stable introduction of immunoglobulin genes into myeloma cells coupled with detailed structural information has permitted use of in vitro mutagenesis methods to generate recombinant antibodies possessing special properties (13, 14) . The generation of chimeric antibodies, in which the gene encoding the antigen-binding portion ofthe immunoglobulin is fused to the gene for another protein (for example, Staphylococcus aureus nuclease, mouse oncogene c-myc, and Klenow fragment of E. coli DNA polymerase I; refs. 2 and 15) and then expressed as a secretion protein, has already been shown with these techniques. The generality of directing secretion of an antibodybinding activity fused to other sequences and concomitantly maintaining bifunctional activities remains to be established.
To evaluate the contribution of these different factors to a luminescent immunoassay reagent we have introduced the aequorin gene from the hydromedusa A. victoria into the coding region ofan antibody gene, as described by Neuberger et al. (2) . When transfected into cell line J558L this fused gene directs the expression of an antibody specific for the 4-hydroxy-3-nitrophenacetyl group (NP) with the bioluminescent activity of aequorin. This chimeric antibody can also be regenerated and activated to produce light while immobilized to a solid-phase antigen, demonstrating its usefulness in an immunoassay format.
Abbreviations: NP, 4-hydroxy-3-nitrophenacetyl; NIP, 4-hydroxy-3-iodo-5-nitrophenacetyl; BSA, bovine serum albumin; PBS, phosphate-buffered saline; Eco-gpt, Escherichia coli xanthine-guanine phosphoribosyltransferase.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (16) . Twenty outer margins were extracted as described (17) . To the aqueous phase from the extraction, 3 vol of ethanol were added and transported back to the laboratory on dry ice. Isolated crude RNA was further purified, as described (17, 18) ; poly(A)+ RNA was precipitated and stored at -700C.
MATERIALS AND METHODS
Diouble-stranded cDNA was prepared essentially as described by Gubler and Hoffman (19) . EcoRI linkers were added, as described (20) . The Tinkered cDNA was sizefractionated on an agarose gel, and cDNA of 400-2000 base pairs was isolated by electroelution onto DEAE membranes (NA45 paper; Schleicher & Schuell). The purified Tinkered cDNA was then ligated to AgtlO dephosphorylated arms (Stratagene) and packaged in vitro into A phage by using Gigapack (Stratagene), according to standard procedures (21) .
The packaged phage were plated on C600Hfl-cells, and plaques were replicated onto nitrocellulose filters for screening by hybridization with standard methods (22) . Oligonucleotide probes based on the aequorin gene sequence were synthesized by an Applied Biosystems machine (12) (5'-ACAAGACAACATTTAGGATTTTGGTACACCATG-GATCCTGCTTGCGA AAAGCTCTACGGT and 5'-GGTG-TACCAAAATCCTAAATGTTGTCTTGTCATCTCAT-CAACATCGAGT TGTCCACITTC). These oligonucleotides were labeled by nick-translation with biotin 11-dUTP (Bethesda Research Laboratories); standard methods were used to generate the probe (17) . After hybridization to the probe, the filters were' developed with the avidin-alkaline phosphatase system (Bethesda Research Laboratories).' Positive clones were cultured as plate lysates and then phage purified with solid-phase anti-A phage antibodies (LambdaSorb; Promega Biotec). The phage DNA was then digested with EcoRI, and inserts were subcloned into pUC18 (23) at the EcoRI site. The methods used in construction of the expression vectors were as described (17) . The isolated gene was sequenced by the method "of Chen and Seeburg (24) .
Construction-of Antibody-Aequorin Chimera. Construction of the fusion required modification of the EcoRI aequorin gene fragment to clone the gene into the Xho I site of vector 186. Vector 186 contains the genomic heavy-chain variable region specific for NP, domain I of the heavy-chain constant region, the hinge of genomic IgG2b, and the gene for E. coli xanthine-guanine phosphoribosyltransferase (Eco-gpt) under control of the simian virus 40 early promoter (14) (see Fig. 1 for overall construction scheme). The (27) . This crude luciferin preparation was redissolved in 1 M HCI in methanol for use in the aequorin photoprotein assays.
The assay of bacterial extracts was as described by Inouye et al. (28) 20 positive clones were identified with this method, indicating an abundance of 0.2% in the enriched gene library. These data agree well with the reported 0.1% aequorin clones (29) . The difference, if significant, is probably due to the size fractionation used in our study. We selected nine of the positive clones for further analysis by EcoRI digests. Three of these clones had inserts of the expected =600-base-pair size and were subcloned into pUC18. (Fig. 1 shows construction of the expression vector.) The HindIII-EcoRI fragment containing the aequorin gene was isolated from the subclone with the largest EcoRI insert. This gene fragment was recloned into a Xho I-EcoRI-digested pXSM13-, as described. The resultant clone pXR3 allows expression of a lacZ-aequorin gene in E. coli via the lac promoter present in pBSM13-; thus the correct clone was potentially identifiable by its activity. To determine whether photoprotein activity was recoverable in lysates from E. coli cultures on induction of lac promoter, we tested lysates and found photoprotein activity at low levels (data not shown). The clone pXR3 was further modified, as described. The resultant clone pXR3i was used as the source of the Xho I fragment for introduction into vector 186 (2) at the Xho I site, generating plasmid p2O5GTi and allowing for the potential expression of the aequorin gene fused to antibody sequences.
Transfections by electroporation yielded -100 anti-NIP-immunoglobulin-positive clones per ,ug of plasmid DNA, with 1 cell in 104 cells being transfected. Four of the culture supernatants from the anti-NIP-immunoglobulin-positive cell lines were assayed for photoprotein activity and found to contain similar levels of activity (range of 2-fold). This narrow range of expression levels was found for previous transfections when using these methods (data not shown).
Characterization of the Chimeric Protein. To further characterize the product of the antibody-aequorin gene fusion on plasmid p2O5GTi, affinity purification of the NIP-binding activity was done as described above.
The profile of an ELISA, measuring antibody-binding activity and the profile of the light activity (data not shown), demonstrates copurification of the antibody and photoprotein activity.
Analysis of the purified material by gel electrophoresis demonstrated protein bands with Mr values of 74,000-76,000 on the nonreducing gel (Fig. 2 Upper, lane 2) and, upon reduction, proteins of 26,000 (the A light chain) and a doublet at Mr 50,000-52,500, (Fig. 2 Upper, lane 1) . These values agree with the molecular weight calculated from the aequorin sequence used plus the variable region of the heavy chain-NP Fab fragment. Furthermore, the Mr derived from the nonreducing gel indicates that the chimeric antibody exists as a Fab' rather than a (Fab')2 fragment (see Fig. 2 Lower). The expected molecular structure is illustrated in Fig. 2 Lower for comparison.
The fusion product was further characterized for its photoprotein activity by titration of the substrate coelenterazine (Fig. 3) . The data are similar to others, as far as comparison can be made lacking detailed data for apoaequorin (28) .
To investigate the usefulness of the protein in an immunoassay format, we determined the ability of the chimeric protein, bound to antigen-coated tubes, to regenerate photoprotein activity. Fig. 4 shows that when chimeric protein bound to solid-phase antigen, coelenterazine addition caused regeneration of normal aequorin activity. 
DISCUSSION
A number of aequorin gene sequences have been described (28, 29) , and comparison ofthe sequence reported here shows that our sequence differs from that described by Inouye et al. (28) at only seven positions, all of which are confirmed silent nucleotide changes. This may indicate gene polymorphism or a multigene family. In this regard, evidence exists from others (29, 30) of multiple aequorin genes and proteins, the sequences and possibly properties of which differ from those of Inouye et al. (28) and ourselves. .. The potential utility of aequorin in assay systems had not been realized due to the sensitivity of the aequorincoelenterazine complex to various chemical methods of labeling and conjugation, which prevented its effective use as a reporter molecule (31) . The availability of recombinant apoaequorin, the stability of which is enhanced relative to holoenzyme and the activity of which can be fully recovered on addition of coelenterazine, may allow development of more flexible assay formats. In particular, the possibility exits of formatting immunoassays where Ca2l ions are present in the initial binding stages but are subsequently removed by washing before activation with coelenterazine.
Our aim in constructing this chimera was to evaluate the potential use of aequorin in immunoassays. The gene fusion generated contained the heavy-chain variable region and IgG2b of the constant region of domain 1 segments ofanti-NP antibody [as described by Neuberger (15); see Fig. 2 Lower] fused to the 5' end of the aequorin gene. NaDodSO4/PAGE analysis of the purified antibody-aequorin fusion protein showed species with Mr values consistent with the predicted product of the gene fusion and its association with the light chain expressed by the J558L myeloma. The finding that most unreduced material was present in a Fab'-like form with a Mr of 74,000-76,000 (Fig. 2 Upper, lane 2) was of interest but not unexpected, as the S. aureus nuclease fusion generated by Neuberger et al. (2) had indicated some interference with dimerization to a (Fab')2-like molecule in such gene fusions. The addition of the light chain is not affected to a significant extent, as shown by the presence of the light chain in the purified product and the copurification of NIP-binding activity and aequorin activity.
In analyzing affinity-purified antibody fusion on reducing gels (Fig. 2 Upper, lane 1) a doublet of bands was resolved at the position for the gene-fusion product. This phenomenon had been seen for fusion of the S. aureus nuclease fusion generated by Neuberger et al. (2) .
Overall, the biochemical analyses provided good evidence that the bifunctional fusion protein was the major species purified. In functional assays, the expressed fusion protein in the supernatant from transfected cells could use either natural or synthetic coelenterazine in generating luminescence and recovery of photoprotein activity. Furthermore, affinity purification of the culture supernatants on a solid-phase antigen copurified photoprotein activity (data not shown). These results provide firm evidence that the major species purified was a bifunctional fusion protein. The photoprotein activities of the aequorin chimera are similar to those reported for aequorin (28, 29, 32) , though stability studies indicate that the construct described here exhibits greater stability than other preparations in prolonged storage as the holoprotein (data not shown). This result was unexpected because published results (31) have suggested that the holoprotein is relatively unstable.
In general, the chimeric protein does not show any significant differences in its photoprotein activity compared with the data available for the native-and bacterial-expressed proteins (28, 29) . Data from the kinetics oflight output, where peak durations are 2-3 s (data not shown), indicate that light-production characteristics from the fusion protein are near those of native aequorin (33) . This fact suggests that other modifications of the N terminus of aequorin are possible, given that addition of a 77-kDa immunoglobulin Fab' has no affect on its activity.
Toward the goal of site-directed labeling of aequorin, we have evaluated the potential of the Fab portion of the fusion protein to act as a target for direct (e.g., biotin) labeling procedures that allow streptavidin capture (unpublished data). The ability of the antibody-aequorin protein to bind to immobilized antigen and subsequently undergo aequorin reactivation has demonstrated its potential in immunoassay development (Fig. 4) . The general utility of this procedure will be further apparent when apoaequorin fusion proteins are produced that contain high-affinity antibody-binding sites for hormones and polypeptides (e.g., glycoprotein hormones, such as thyroid-stimulating hormone and viral antigens) of low concentrations presently difficult to measure.
In conclusion, this system for expression of aequorin is potentially valuable for several types of study. Because the fusion protein can be readily purified and relative specific activities can be accurately determined, the system offers an ideal method for structure-activity studies of the aequorin gene family by, for example, site-directed mutagenesis. The importance of a method for achieving high purity cannot be overstated because the photoactivity of aequorin is greatly affected by Ca2' and sulfur-containing compounds, normally present in cruder preparations (34) . In addition, the preliminary immunoassay results presented here suggest that chimeric antibody-aequorin proteins will find an important application in high-sensitivity immunoassays.
